I tried explaining this previously. CANN *probably* has an economies of scale advantage in Australia - although being a market share leader is far more valuable when you’re profitable.
CANN definitely do not have an economies of scale advantage worldwide.
This is the point myself and a lot of people on here have been trying to make - until Australia has a more market friendly approach to MC the industry is going to struggle here. The prescription guidelines need to change for a start.
CAN Price at posting:
13.5¢ Sentiment: None Disclosure: Not Held
